Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free GERN Stock Alerts

Geron (GERN) Financials

Geron logo
$1.23 -0.06 (-4.65%)
Closing price 04:00 PM Eastern
Extended Trading
$1.25 +0.02 (+1.22%)
As of 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Geron

Annual Income Statements for Geron

This table shows Geron's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Consolidated Net Income / (Loss)		 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Net Income / (Loss) Continuing Operations		 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Total Pre-Tax Income 		0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Total Operating Income		 -0.56 -31 -29 -31 -73 -77 -114 -139 -194 -174 -69
Total Gross Profit		 36 6.16 1.07 1.07 0.46 0.25 1.39 0.00 0.00 76 179
Total Revenue		 36 6.16 1.07 1.07 0.46 0.25 1.39 0.00 0.00 77 184
Operating Revenue		 36 6.16 1.07 1.07 0.46 0.25 1.39 0.00 0.00 77 184
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.26 4.75
Operating Cost of Revenue		 - - - - - - - 0.00 0.00 1.26 4.75
Total Operating Expenses		 37 37 30 32 73 77 115 139 194 249 248
Selling, General & Admin Expense		 18 19 19 19 21 26 30 44 69 146 159
Research & Development Expense		 18 18 11 13 52 51 86 96 125 104 71
Restructuring Charge		 1.31 - - - - - - - 0.00 0.00 17
Total Other Income / (Expense), net		 0.61 1.11 1.34 4.06 3.96 1.30 -2.11 -3.35 9.82 -0.84 -15
Interest Expense		 - - - 0.00 0.00 0.76 3.74 6.88 8.31 20 33
Interest & Investment Income		 0.68 1.19 1.42 3.25 4.22 1.83 0.53 2.53 18 20 18
Other Income / (Expense), net		 -0.07 -0.08 -0.08 0.81 -0.26 0.23 1.10 1.00 -0.02 -0.24 -0.38
Basic Earnings per Share		 $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27) ($0.13)
Weighted Average Basic Shares Outstanding		 158.04M 159.05M 159.22M 176.50M 190.16M 271.46M 327.63M 380.78M 570.65M 646.03M 666.66M
Diluted Earnings per Share		 $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27) ($0.13)
Weighted Average Diluted Shares Outstanding		 162.66M 159.05M 159.22M 176.50M 190.16M 271.46M 327.63M 380.78M 570.65M 646.03M 666.66M
Weighted Average Basic & Diluted Shares Outstanding		 158.92M 159.05M 159.22M 176.50M 190.16M 271.46M 327.63M 508.72M 546.06M 636.90M 640.54M

Quarterly Income Statements for Geron

This table shows Geron's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -45 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64
Consolidated Net Income / (Loss)		 -45 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64
Net Income / (Loss) Continuing Operations		 -45 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64
Total Pre-Tax Income 		-45 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64
Total Operating Income		 -48 -54 -56 -69 -28 -20 -17 -12 -14 -26 0.16
Total Gross Profit		 0.16 -0.19 0.30 0.87 28 47 38 48 46 47 50
Total Revenue		 0.16 -0.19 0.30 0.88 28 48 40 49 47 48 52
Operating Revenue		 0.16 - 0.30 0.88 28 - 40 49 47 48 52
Total Cost of Revenue		 0.00 - 0.00 0.02 0.46 0.78 1.21 1.19 1.04 1.31 1.69
Operating Cost of Revenue		 0.00 - 0.00 0.02 0.46 - 1.21 1.19 1.04 1.31 1.69
Total Operating Expenses		 48 54 56 70 56 67 55 60 60 72 50
Selling, General & Admin Expense		 18 21 27 39 36 43 40 39 39 42 35
Research & Development Expense		 29 33 29 31 20 23 15 22 21 14 15
Restructuring Charge		 - - - - - - 0.00 - - - -0.39
Total Other Income / (Expense), net		 2.81 2.32 0.74 1.95 1.77 -5.30 -3.13 -3.92 -4.54 -3.32 -3.80
Interest Expense		 2.07 2.32 3.43 3.32 3.05 10 8.20 8.52 8.64 7.30 7.15
Interest & Investment Income		 4.97 4.60 4.24 5.33 4.88 5.16 5.15 4.66 4.26 4.05 3.42
Other Income / (Expense), net		 -0.09 0.04 -0.06 -0.06 -0.06 -0.05 -0.08 -0.06 -0.16 -0.07 -0.07
Basic Earnings per Share		 ($0.08) ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03) ($0.02) ($0.03) ($0.05) ($0.01)
Weighted Average Basic Shares Outstanding		 579.51M 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M 666.17M 667.10M 666.66M 669.38K
Diluted Earnings per Share		 ($0.08) ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03) ($0.02) ($0.03) ($0.05) ($0.01)
Weighted Average Diluted Shares Outstanding		 579.51M 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M 666.17M 667.10M 666.66M 669.38K
Weighted Average Basic & Diluted Shares Outstanding		 543.06M 546.06M 593.13M 602.80M 604.50M 636.90M 636.92M 638.02M 638.36M 640.54M 641.52M

Annual Cash Flow Statements for Geron

This table details how cash moves in and out of Geron's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -22 -8.44 3.53 -5.76 3.07 -3.63 25 22 14 9.74 -1.44
Net Cash From Operating Activities		 -24 -18 -21 -21 -44 -67 -96 -127 -168 -219 -111
Net Cash From Continuing Operating Activities		 -24 -18 -21 -21 -44 -67 -96 -127 -168 -219 -111
Net Income / (Loss) Continuing Operations		 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Consolidated Net Income / (Loss)		 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Depreciation Expense		 0.06 0.08 0.08 0.06 0.06 0.16 0.22 0.29 0.44 0.55 0.47
Amortization Expense		 2.10 0.55 0.27 -0.98 -0.82 1.77 2.89 0.94 -9.47 -12 -5.12
Non-Cash Adjustments To Reconcile Net Income		 11 10 6.76 7.55 18 6.73 5.90 6.88 21 35 32
Changes in Operating Assets and Liabilities, net		 -37 0.32 0.26 -0.63 7.10 0.30 12 6.41 4.57 -67 -55
Net Cash From Investing Activities		 0.07 8.76 23 -78 27 -105 72 62 -180 -106 107
Net Cash From Continuing Investing Activities		 0.07 8.76 23 -78 27 -105 72 62 -180 -106 107
Purchase of Property, Plant & Equipment		 -0.09 -0.06 - -0.02 -0.41 -0.40 -0.21 -0.43 -0.83 -0.68 -0.05
Purchase of Investments		 -206 -129 -100 -188 -153 -313 -177 -258 -476 -477 -304
Sale and/or Maturity of Investments		 207 138 123 111 181 208 248 321 296 372 412
Net Cash From Financing Activities		 2.58 1.17 1.11 93 19 168 49 87 362 334 2.27
Net Cash From Continuing Financing Activities		 2.58 1.17 1.11 93 19 168 49 87 362 334 2.27
Repayment of Debt		 - - - - - - - 0.00 0.00 -87 0.00
Issuance of Debt		 - - - 0.00 0.00 24 25 0.00 30 121 0.00
Issuance of Common Equity		 2.58 1.17 1.11 93 19 144 21 72 226 173 2.27
Other Financing Activities, net		 - - - 0.00 0.00 0.02 2.48 15 106 126 0.00
Effect of Exchange Rate Changes		 - - - - - - 0.00 0.02 -0.03 -0.01 0.09

Quarterly Cash Flow Statements for Geron

This table details how cash moves in and out of Geron's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -26 40 120 -73 -56 19 4.73 -6.01 0.39 -0.55 -8.66
Net Cash From Operating Activities		 -51 -41 -62 -53 -59 -44 -48 -27 -14 -22 -63
Net Cash From Continuing Operating Activities		 -51 -41 -62 -53 -59 -44 -48 -27 -14 -22 -63
Net Income / (Loss) Continuing Operations		 -45 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64
Consolidated Net Income / (Loss)		 -45 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64
Depreciation Expense		 0.11 0.11 0.11 0.26 0.03 0.14 0.13 0.13 0.13 0.09 0.13
Amortization Expense		 -2.96 -2.34 -1.40 -1.67 -1.82 -7.23 -1.78 -1.30 -1.07 -0.97 -0.59
Non-Cash Adjustments To Reconcile Net Income		 7.64 6.08 4.97 13 6.91 10 8.67 8.71 8.11 6.61 5.10
Changes in Operating Assets and Liabilities, net		 -11 7.18 -11 2.67 -38 -22 -35 -19 -2.32 1.08 -64
Net Cash From Investing Activities		 -4.71 48 34 -36 -0.55 -104 52 20 13 21 52
Net Cash From Continuing Investing Activities		 -4.71 48 34 -36 -0.55 -104 52 20 13 21 52
Purchase of Property, Plant & Equipment		 -0.19 -0.06 -0.62 -0.21 - 0.14 0.03 -0.17 0.09 - -0.25
Purchase of Investments		 -104 -16 -66 -161 -66 -185 -46 -77 -77 -104 -35
Sale and/or Maturity of Investments		 99 64 100 125 65 81 99 97 90 125 87
Net Cash From Financing Activities		 29 33 148 17 3.58 166 0.26 1.09 0.54 0.38 2.43
Net Cash From Continuing Financing Activities		 29 33 148 17 3.58 166 0.26 1.09 0.54 0.38 2.43
Issuance of Common Equity		 1.04 3.58 148 16 3.57 5.62 0.26 1.09 0.54 0.38 0.91
Other Financing Activities, net		 28 - 0.05 0.37 0.00 126 0.00 - - - 1.51
Effect of Exchange Rate Changes		 0.01 -0.02 -0.01 -0.02 0.05 - 0.02 0.00 0.08 -0.01 -0.04

Annual Balance Sheets for Geron

This table presents Geron's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 149 130 110 185 166 271 226 191 394 594 571
Total Current Assets		 116 116 96 166 142 200 187 180 341 491 520
Cash & Equivalents		 21 13 16 11 14 9.93 35 57 70 79 78
Restricted Cash		 0.27 0.27 0.27 0.27 0.27 0.36 0.36 0.36 1.12 1.86 1.88
Short-Term Investments		 93 102 78 153 126 186 149 116 264 328 280
Note & Lease Receivable		 1.21 0.48 0.44 1.17 0.80 0.72 1.76 3.14 1.66 2.85 2.24
Accounts Receivable		 - - - - - - - - 0.00 36 37
Inventories, net		 - - - - - - - - 0.00 39 117
Prepaid Expenses		 0.65 0.52 0.58 1.33 1.21 2.50 1.36 3.99 4.88 5.05 4.61
Plant, Property, & Equipment, net		 0.21 0.18 0.10 0.06 0.41 0.66 0.65 0.79 1.18 1.31 0.88
Total Noncurrent Assets		 33 14 14 19 24 70 38 9.54 52 101 49
Long-Term Investments		 33 14 14 19 20 63 29 0.00 43 95 41
Other Noncurrent Operating Assets		 - - - 0.59 3.85 6.83 9.53 9.54 8.25 6.96 8.10
Total Liabilities & Shareholders' Equity		 149 130 110 185 166 271 226 191 394 594 571
Total Liabilities		 6.63 7.87 6.52 7.55 30 60 100 111 146 313 345
Total Current Liabilities		 6.63 7.87 6.52 7.55 28 31 46 77 108 88 112
Accounts Payable		 0.16 0.23 0.50 0.98 1.18 6.92 6.69 10 6.16 8.60 11
Accrued Expenses		 3.45 4.80 0.93 1.32 7.53 15 30 33 40 36 51
Current Employee Benefit Liabilities		 3.03 2.84 3.39 2.64 4.83 8.22 8.10 12 14 23 30
Other Current Liabilities		 - - 1.70 2.61 15 0.88 0.90 0.93 0.95 21 18
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.00 2.20 29 54 34 38 225 233
Long-Term Debt		 - - - - 0.00 24 50 30 35 118 120
Other Noncurrent Operating Liabilities		 - - - - 2.20 4.80 4.27 3.67 3.01 107 114
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 142 122 104 178 135 211 126 80 248 280 226
Total Preferred & Common Equity		 142 122 104 178 135 211 126 80 248 280 226
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 142 122 104 178 135 211 126 80 248 280 226
Common Stock		 1,071 1,080 1,090 1,189 1,215 1,366 1,398 1,494 1,846 2,052 2,081
Retained Earnings		 -928 -958 -986 -1,011 -1,080 -1,156 -1,272 -1,414 -1,598 -1,772 -1,856
Accumulated Other Comprehensive Income / (Loss)		 -0.21 -0.05 -0.21 -0.18 0.13 0.08 -0.17 -0.22 0.19 0.26 0.27

Quarterly Balance Sheets for Geron

This table presents Geron's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 233 425 415 413 482 449 445 562 555 567 534
Total Current Assets		 222 387 377 335 452 373 398 496 506 522 499
Cash & Equivalents		 61 113 57 31 190 117 60 84 78 78 69
Restricted Cash		 0.36 0.37 0.54 0.54 1.12 1.12 1.85 1.87 1.87 1.88 1.88
Short-Term Investments		 134 268 314 283 253 246 279 313 310 302 244
Note & Lease Receivable		 22 1.60 1.19 15 1.63 2.25 2.08 2.82 2.76 2.30 2.21
Accounts Receivable		 - - - - - 0.87 28 31 37 35 42
Inventories, net		 - - - - - 0.77 20 56 69 95 133
Prepaid Expenses		 4.70 4.32 4.18 6.27 5.71 5.55 6.06 6.82 7.26 6.86 6.86
Plant, Property, & Equipment, net		 0.73 1.07 1.15 1.23 1.68 1.63 1.60 1.15 1.19 0.97 1.00
Total Noncurrent Assets		 9.80 37 37 77 29 74 45 66 48 44 35
Long-Term Investments		 0.00 28 28 68 21 67 37 59 43 39 27
Other Noncurrent Operating Assets		 9.80 8.69 8.59 8.88 8.10 7.96 7.99 6.74 5.67 5.00 7.90
Total Liabilities & Shareholders' Equity		 233 425 415 413 482 449 445 562 555 567 534
Total Liabilities		 124 99 117 122 137 143 153 294 296 319 305
Total Current Liabilities		 83 44 73 89 123 104 138 63 64 88 74
Accounts Payable		 8.18 3.38 7.67 14 9.99 5.62 14 8.03 8.23 11 13
Accrued Expenses		 53 35 45 42 34 39 36 29 26 40 31
Current Employee Benefit Liabilities		 7.64 4.91 8.23 11 6.79 11 15 9.60 11 16 9.49
Other Current Liabilities		 0.92 0.93 0.79 0.94 0.96 0.96 0.97 17 18 20 20
Total Noncurrent Liabilities		 42 55 44 33 14 39 15 231 231 231 231
Long-Term Debt		 38 51 41 30 11 37 12 119 119 119 120
Other Noncurrent Operating Liabilities		 3.83 3.51 3.50 3.18 2.83 2.65 2.46 112 112 112 112
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 108 326 298 291 345 307 292 268 260 249 229
Total Preferred & Common Equity		 108 326 298 291 345 307 292 268 260 249 229
Preferred Stock		 - - - - - - - - - - 0.00
Total Common Equity		 108 326 298 291 345 307 292 268 260 249 229
Common Stock		 1,480 1,778 1,800 1,837 1,998 2,028 2,038 2,060 2,068 2,075 2,089
Retained Earnings		 -1,371 -1,452 -1,501 -1,546 -1,653 -1,721 -1,747 -1,792 -1,809 -1,827 -1,859
Accumulated Other Comprehensive Income / (Loss)		 -0.62 -0.16 -0.95 -0.95 -0.27 -0.54 1.02 0.30 0.12 0.41 -0.19

Annual Metrics And Ratios for Geron

This table displays calculated financial ratios and metrics derived from Geron's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - - 638,355,275.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 638,355,275.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -0.13
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -0.56 -21 -20 -22 -51 -54 -80 -97 -136 -122 -48
Return On Investment Capital (ROIC_SIMPLE)		 -0.39% -17.53% -19.73% -12.24% -37.55% -22.91% -45.28% -73.95% -41.15% -30.49% -13.90%
Earnings before Interest and Taxes (EBIT)		 -0.63 -31 -29 -30 -73 -77 -113 -138 -194 -174 -69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1.52 -30 -29 -31 -74 -75 -110 -136 -203 -186 -74
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -36 -19 -22 -23 -31 -53 -68 -92 -129 -66 -96
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -4.57 -6.69 -5.40 -4.41 -24 -25 -36 -42 -48 -104 -56
Increase / (Decrease) in Invested Capital		 35 -2.11 1.29 0.99 -20 -0.95 -11 -5.46 -6.26 -56 48
Book Value per Share		 $0.90 $0.77 $0.65 $0.95 $0.68 $0.68 $0.39 $0.21 $0.46 $0.46 $0.35
Tangible Book Value per Share		 $0.90 $0.77 $0.65 $0.95 $0.68 $0.68 $0.39 $0.21 $0.46 $0.46 $0.35
Total Capital		 142 122 104 178 135 235 176 131 330 399 345
Total Debt		 0.00 0.00 0.00 0.00 0.00 24 50 51 82 118 120
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 24 50 30 35 118 120
Net Debt		 -147 -129 -109 -182 -159 -236 -163 -122 -296 -384 -282
Capital Expenditures (CapEx)		 0.09 0.04 0.00 0.02 0.41 0.06 -1.39 0.43 0.83 0.68 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -4.78 -6.87 -5.50 -5.05 -26 -28 -42 -49 -55 -5.73 49
Debt-free Net Working Capital (DFNWC)		 109 108 89 159 113 169 142 124 280 403 409
Net Working Capital (NWC)		 109 108 89 159 113 169 142 104 233 403 409
Net Nonoperating Expense (NNE)		 -0.61 8.08 7.44 5.27 18 22 36 45 48 53 35
Net Nonoperating Obligations (NNO)		 -147 -129 -109 -182 -159 -236 -163 -122 -296 -384 -282
Total Depreciation and Amortization (D&A)		 2.15 0.63 0.35 -0.92 -0.76 1.93 3.10 1.23 -9.03 -12 -4.65
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27) ($0.13)
Adjusted Weighted Average Basic Shares Outstanding		 158.04M 159.05M 159.22M 186.39M 200.34M 318.53M 323.73M 380.78M 570.65M 646.03M 666.66M
Adjusted Diluted Earnings per Share		 $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27) ($0.13)
Adjusted Weighted Average Diluted Shares Outstanding		 162.66M 159.05M 159.22M 186.39M 200.34M 318.53M 323.73M 380.78M 570.65M 646.03M 666.66M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($0.15) ($0.36) ($0.28) ($0.35) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 158.92M 159.16M 160.65M 176.50M 190.16M 271.46M 327.63M 508.72M 546.06M 636.90M 640.54M
Normalized Net Operating Profit after Tax (NOPAT)		 0.52 -21 -20 -22 -51 -54 -80 -97 -136 -122 -36
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Geron

This table displays calculated financial ratios and metrics derived from Geron's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - 638,355,275.00 640,544,661.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 638,355,275.00 640,544,661.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - -0.05 -0.01
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -44.78% 54.05% 0.00% 2,941.38% 17,138.41% 24,888.08% 12,927.30% 5,459.64% 67.05% - 30.89%
EBITDA Growth		 -27.10% -33.30% -39.24% -29.49% 40.53% 51.86% 67.93% 80.68% 50.13% - 97.98%
EBIT Growth		 -19.00% -29.58% -40.30% -33.55% 40.72% 62.95% 70.13% 81.97% 50.32% - 100.50%
NOPAT Growth		 -19.18% -29.41% -40.01% -33.46% 40.74% 63.07% 70.24% 82.04% 50.78% - 100.95%
Net Income Growth		 -9.14% -21.90% -45.30% -36.88% 40.97% 51.22% 64.19% 75.70% 30.32% - 81.64%
EPS Growth		 20.00% 27.27% -28.57% -11.11% 50.00% 50.00% 66.67% 80.00% 25.00% - 66.67%
Operating Cash Flow Growth		 -71.86% -16.36% -34.27% -80.66% -15.94% -7.35% 22.93% 48.74% 76.97% - -31.11%
Free Cash Flow Firm Growth		 -41.24% -32.79% -26.60% -335.14% -86.58% 232.00% 163.90% 108.77% 172.75% - -464.09%
Invested Capital Growth		 -8.70% -14.93% -17.59% 19.74% 92.84% -115.99% -89.01% -34.40% -1,797.84% - 111.29%
Revenue Q/Q Growth		 465.52% -217.68% 100.00% 0.00% 3,105.33% 69.22% -17.22% 23.82% -3.69% - 7.96%
EBITDA Q/Q Growth		 7.54% -11.71% -1.79% -23.17% 57.54% 9.57% 32.19% 25.79% -9.57% - 98.59%
EBIT Q/Q Growth		 8.19% -13.72% -3.59% -23.49% 59.25% 28.93% 16.47% 25.45% -12.25% - 100.33%
NOPAT Q/Q Growth		 8.35% -14.02% -3.40% -23.51% 59.31% 28.94% 16.69% 25.44% -11.51% - 100.62%
Net Income Q/Q Growth		 8.98% -16.00% -6.57% -21.65% 60.75% 4.14% 21.76% 17.44% -12.54% - 87.38%
EPS Q/Q Growth		 11.11% 0.00% -12.50% -11.11% 60.00% 0.00% 25.00% 33.33% -50.00% - 80.00%
Operating Cash Flow Q/Q Growth		 -71.75% 19.48% -52.07% 14.10% -10.22% 25.44% -9.18% 42.86% 50.48% - -185.07%
Free Cash Flow Firm Q/Q Growth		 -124.76% -5.17% -6.21% -73.32% 3.63% 174.41% -48.58% -76.22% 699.50% - -18.19%
Invested Capital Q/Q Growth		 21.45% -22.47% 22.57% -7.75% 92.99% -3,594.54% 32.24% 23.38% 1.06% - 114.32%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 0.00% 0.00% 98.07% 98.39% 98.36% 96.95% 97.57% 97.79% - 96.74%
EBITDA Margin		 -30,826.22% 0.00% 0.00% -8,027.55% -106.34% -56.83% -46.55% -27.90% -31.74% - -0.72%
Operating Margin		 -29,031.71% 0.00% 0.00% -7,860.88% -99.80% -41.91% -42.18% -25.40% -29.40% - 0.30%
EBIT Margin		 -29,087.80% 0.00% 0.00% -7,868.03% -100.02% -42.01% -42.39% -25.52% -29.75% - 0.16%
Profit (Net Income) Margin		 -27,320.12% 0.00% 0.00% -7,639.80% -93.55% -52.99% -50.08% -33.39% -39.02% - -7.03%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00%
Interest Burden Percent		 93.92% 95.81% 98.57% 97.10% 93.53% 126.14% 118.16% 130.84% 131.18% - -4,335.71%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Equity (ROE)		 -87.66% -112.29% -60.04% -72.56% -69.03% -66.09% -45.35% -31.09% -29.57% - -27.07%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - -1,439.74%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% -15.52% -6.75% -6.55% -9.44% -8.36% -10.78% - 0.06%
Return on Assets (ROA)		 0.00% 0.00% 0.00% -15.07% -6.32% -8.26% -11.15% -10.93% -14.14% - -2.51%
Return on Common Equity (ROCE)		 -87.66% -112.29% -60.04% -72.56% -69.03% -66.09% -45.35% -31.09% -29.57% - -27.07%
Return on Equity Simple (ROE_SIMPLE)		 -60.14% 0.00% -58.40% -71.59% -68.83% 0.00% -51.83% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)		 -33 -38 -39 -49 -20 -14 -12 -8.72 -9.72 -18 0.11
NOPAT Margin		 -20,322.20% 0.00% 0.00% -5,502.62% -69.86% -29.34% -29.53% -17.78% -20.58% - 0.21%
Net Nonoperating Expense Percent (NNEP)		 -4.84% -6.68% -4.35% -5.42% -2.14% -3.33% -2.26% -2.32% -2.92% - -1.34%
Return On Investment Capital (ROIC_SIMPLE)		 -9.73% -11.52% -9.19% -12.44% -5.25% -3.52% -3.02% -2.30% -2.64% -5.18% 0.03%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 1.93% 1.61% 1.64% 3.05% 2.43% 2.21% - 3.26%
SG&A Expenses to Revenue		 11,189.02% 0.00% 0.00% 4,469.27% 126.90% 90.66% 101.06% 78.64% 82.58% - 68.34%
R&D to Revenue		 17,942.68% 0.00% 0.00% 3,489.68% 71.29% 48.98% 38.07% 44.33% 44.61% - 28.85%
Operating Expenses to Revenue		 29,131.71% 0.00% 0.00% 7,958.96% 198.19% 139.64% 139.13% 122.97% 127.20% - 96.43%
Earnings before Interest and Taxes (EBIT)		 -48 -54 -56 -69 -28 -20 -17 -13 -14 -26 0.08
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -51 -56 -57 -71 -30 -27 -18 -14 -15 -26 -0.37
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.82 4.62 5.23 8.20 9.36 7.63 3.78 3.46 3.51 - 4.17
Price to Tangible Book Value (P/TBV)		 3.82 4.62 5.23 8.20 9.36 7.63 3.78 3.46 3.51 - 4.17
Price to Revenue (P/Rev)		 0.00 0.00 0.00 2,948.28 94.50 27.79 8.71 5.46 4.77 - 4.87
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 92.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 2,541.57 84.31 22.80 5.79 3.55 3.12 - 3.74
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 87.79 - 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.18 0.33 0.24 0.27 0.29 0.42 0.44 0.46 0.48 - 0.52
Long-Term Debt to Equity		 0.10 0.14 0.03 0.12 0.04 0.42 0.44 0.46 0.48 - 0.52
Financial Leverage		 -1.19 -1.28 -1.10 -1.15 -1.07 -1.29 -1.18 -1.17 -1.10 - -1.13
Leverage Ratio		 1.62 1.78 1.35 1.43 1.47 1.87 1.70 1.77 1.87 - 2.20
Compound Leverage Factor		 1.52 1.71 1.33 1.39 1.38 2.36 2.01 2.32 2.45 - -95.60
Debt to Total Capital		 15.15% 24.84% 19.35% 21.39% 22.29% 29.71% 30.68% 31.44% 32.41% - 34.34%
Short-Term Debt to Total Capital		 6.44% 14.21% 16.73% 12.03% 19.03% 0.00% 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital		 8.71% 10.63% 2.62% 9.36% 3.26% 29.71% 30.68% 31.44% 32.41% - 34.34%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 84.85% 75.16% 80.65% 78.61% 77.71% 70.29% 69.32% 68.56% 67.59% - 65.66%
Debt to EBITDA		 -0.27 -0.40 -0.38 -0.35 -0.39 -0.64 -0.81 -1.33 -1.61 - -2.16
Net Debt to EBITDA		 1.75 1.46 1.74 1.47 1.37 2.07 2.31 3.51 4.07 - 3.98
Long-Term Debt to EBITDA		 -0.16 -0.17 -0.05 -0.16 -0.06 -0.64 -0.81 -1.33 -1.61 - -2.16
Debt to NOPAT		 -0.41 -0.60 -0.56 -0.52 -0.58 -0.97 -1.26 -2.20 -2.70 - -3.31
Net Debt to NOPAT		 2.60 2.18 2.60 2.18 2.03 3.16 3.60 5.79 6.84 - 6.11
Long-Term Debt to NOPAT		 -0.23 -0.26 -0.08 -0.23 -0.08 -0.97 -1.26 -2.20 -2.70 - -3.31
Altman Z-Score		 0.53 -0.72 3.51 5.43 5.82 0.75 -1.36 -1.56 -1.70 - -1.67
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.75 3.16 3.67 3.61 2.89 5.56 7.87 7.87 5.96 - 6.78
Quick Ratio		 3.67 3.10 3.61 3.53 2.68 5.04 6.84 6.65 4.77 - 4.85
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -30 -32 -34 -58 -56 42 22 5.12 41 -66 -78
Operating Cash Flow to CapEx		 -26,478.65% -63,965.63% -10,122.44% -25,960.19% 0.00% 0.00% 0.00% -16,126.47% 0.00% - -24,962.70%
Free Cash Flow to Firm to Interest Expense		 -14.61 -13.67 -9.82 -17.60 -18.48 4.02 2.63 0.60 4.74 - -10.97
Operating Cash Flow to Interest Expense		 -24.61 -17.64 -18.13 -16.11 -19.35 -4.22 -5.85 -3.22 -1.57 - -8.80
Operating Cash Flow Less CapEx to Interest Expense		 -24.70 -17.67 -18.31 -16.17 -19.35 -4.21 -5.85 -3.24 -1.56 - -8.84
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.07 0.16 0.22 0.33 0.36 - 0.36
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.77 5.79 - 5.37
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.07 - 0.06
Fixed Asset Turnover		 0.00 0.00 0.00 0.62 20.50 61.92 82.24 116.84 142.84 - 182.69
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.03 0.17 0.27 0.53 0.34 - 0.50
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 41.60 63.06 - 67.98
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3,509.37 5,001.46 - 6,611.62
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 142,704.26 10,578.83 2,144.08 1,336.06 695.16 1,073.95 - 724.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 -142,704.26 -10,578.83 -2,144.08 -1,336.06 2,855.81 3,990.57 - 5,955.60
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -39 -48 -37 -40 -2.82 -104 -71 -54 -54 -56 7.97
Invested Capital Turnover		 0.00 0.00 0.00 -0.02 -1.37 -1.01 -2.16 -3.49 -6.51 - -6.27
Increase / (Decrease) in Invested Capital		 -3.15 -6.26 -5.59 9.89 37 -56 -33 -14 -51 48 79
Enterprise Value (EV)		 780 850 1,420 2,168 2,442 1,755 674 584 572 - 733
Market Capitalization		 1,110 1,146 1,802 2,515 2,737 2,140 1,013 898 874 - 954
Book Value per Share		 $0.56 $0.46 $0.63 $0.52 $0.48 $0.46 $0.42 $0.41 $0.39 $0.35 $0.36
Tangible Book Value per Share		 $0.56 $0.46 $0.63 $0.52 $0.48 $0.46 $0.42 $0.41 $0.39 $0.35 $0.36
Total Capital		 343 330 428 390 376 399 387 379 368 345 349
Total Debt		 52 82 83 83 84 118 119 119 119 120 120
Total Long-Term Debt		 30 35 11 37 12 118 119 119 119 120 120
Net Debt		 -330 -296 -382 -347 -295 -384 -339 -314 -302 -282 -221
Capital Expenditures (CapEx)		 0.19 0.06 0.62 0.21 0.00 -0.14 -0.03 0.17 -0.09 0.00 0.25
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -46 -55 -44 -47 -9.94 -5.73 34 51 52 49 111
Debt-free Net Working Capital (DFNWC)		 268 280 400 317 332 403 433 441 435 409 425
Net Working Capital (NWC)		 246 233 328 270 260 403 433 441 435 409 425
Net Nonoperating Expense (NNE)		 11 14 16 19 6.70 11 8.14 7.66 8.71 11 3.75
Net Nonoperating Obligations (NNO)		 -330 -296 -382 -347 -295 -384 -339 -314 -302 -282 -221
Total Depreciation and Amortization (D&A)		 -2.85 -2.23 -1.29 -1.41 -1.79 -7.09 -1.65 -1.17 -0.94 -0.89 -0.46
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% -5,530.13% -34.33% -7.44% 29.23% 31.29% 28.47% - 56.43%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 37,126.03% 1,145.32% 523.02% 372.11% 268.36% 236.98% - 216.69%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 31,625.79% 898.22% 523.02% 372.11% 268.36% 236.98% - 216.69%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.08) ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03) ($0.02) ($0.03) ($0.05) ($0.01)
Adjusted Weighted Average Basic Shares Outstanding		 579.51M 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M 666.17M 667.10M 666.66M 669.38K
Adjusted Diluted Earnings per Share		 ($0.08) ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03) ($0.02) ($0.03) ($0.05) ($0.01)
Adjusted Weighted Average Diluted Shares Outstanding		 579.51M 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M 666.17M 667.10M 666.66M 669.38K
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 543.06M 546.06M 593.13M 602.80M 604.50M 636.90M 636.92M 638.02M 638.36M 640.54M 641.52M
Normalized Net Operating Profit after Tax (NOPAT)		 -33 -38 -39 -49 -20 -14 -12 -8.72 -9.72 -18 -0.17
Normalized NOPAT Margin		 -20,322.20% 0.00% 0.00% -5,502.62% -69.86% -29.34% -29.53% -17.78% -20.58% - -0.32%
Pre Tax Income Margin		 -27,320.12% 0.00% 0.00% -7,639.80% -93.55% -52.99% -50.08% -33.39% -39.02% - -7.03%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -23.09 -23.37 -16.37 -20.91 -9.28 -1.93 -2.05 -1.47 -1.63 - 0.01
NOPAT to Interest Expense		 -16.13 -16.37 -11.45 -14.62 -6.48 -1.35 -1.43 -1.02 -1.12 - 0.02
EBIT Less CapEx to Interest Expense		 -23.18 -23.40 -16.55 -20.97 -9.28 -1.92 -2.04 -1.49 -1.61 - -0.02
NOPAT Less CapEx to Interest Expense		 -16.22 -16.40 -11.63 -14.68 -6.48 -1.33 -1.42 -1.04 -1.11 - -0.02
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%

Financials Breakdown Chart

Key Financial Trends

The following is a concise, data-driven look at Geron (GERN) using the last four years of quarterly statements, focusing on Q4 2025 and nearby periods. Key takeaways for retail investors are below, with trends in profitability, cash flow, and balance sheet health highlighted.

  • High gross margin in Q4 2025: Gross profit of $46.709M on revenue of $48.015M, implying a gross margin of about 97% for that quarter.
  • Steady quarterly revenue in 2025: Revenue in the mid-40s to high-40s millions per quarter (e.g., 48.0M in Q4 2025), indicating a relatively stable top line relative to earlier volatile periods.
  • Liquidity remains solid near-term: Cash & equivalents totaled about $78.1M on the Q3 2025 balance sheet, providing a visible liquidity cushion.
  • Investing activities generated cash in Q4 2025: Net cash from continuing investing activities was approximately +$21.1M in Q4 2025, driven by selling investments that offset operating outflows.
  • Solid equity position amid ongoing losses: Total equity around $248.7M in Q3 2025 suggests a cushion for funding activities, alongside Total assets of about $567.4M.
  • Shares outstanding broadly flat: Weighted average shares outstanding hovered around 0.64–0.67B across 2025, with no dramatic dilution implied in these quarters (e.g., ~666.7M basic/diluted in Q4 2025).
  • Profitability remains negative (expected for biotech): Net income in all 2025 quarters is negative (e.g., -$28.86M in Q4 2025), reflecting ongoing R&D and operating costs common to development-stage biotechs.
  • Ongoing operating cash burn: Net cash from continuing operating activities was negative in every 2025 quarter (e.g., -$22.07M in Q4 2025; -$13.58M in Q3 2025), indicating cash burn from core operations.
  • Heavy investing outflows in several quarters: Recurrent large purchases of investments (e.g., Q4 2025 -$104.22M; Q3 2025 -$77.03M; Q2 2025 -$76.70M) show substantial cash used for investment activity, with occasional inflows from sales.
  • R&D and operating expenses remain a primary driver of losses: 2025 quarters show meaningful R&D and SG&A costs (e.g., Q4 2025 R&D $13.55M; SG&A $41.67M), underscoring ongoing investment in pipeline and operations that suppress near-term profits.
05/18/26 07:28 PM ETAI Generated. May Contain Errors.

Geron Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Geron's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Geron's net income appears to be on an upward trend, with a most recent value of -$83.50 million in 2025, falling from $46 thousand in 2015. The previous period was -$174.57 million in 2024. Check out Geron's forecast to explore projected trends and price targets.

Geron's total operating income in 2025 was -$68.59 million, based on the following breakdown:
  • Total Gross Profit: $179.14 million
  • Total Operating Expenses: $247.72 million

Over the last 10 years, Geron's total revenue changed from $36.37 million in 2015 to $183.88 million in 2025, a change of 405.6%.

Geron's total liabilities were at $344.67 million at the end of 2025, a 10.0% increase from 2024, and a 5,095.5% increase since 2015.

In the past 10 years, Geron's cash and equivalents has ranged from $9.93 million in 2020 to $79.02 million in 2024, and is currently $77.56 million as of their latest financial filing in 2025.

Over the last 10 years, Geron's book value per share changed from 0.90 in 2015 to 0.35 in 2025, a change of -60.6%.


Related Companies

Financial statements for NASDAQ:GERN last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Musk's shopping list: batteries ✓ solar ✓ data ✓ power ___
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...
Behind the Markets | Sponsoredtc pixel
Your $29.97 book is free today
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
SpaceX just split its stock 5-for-1
SpaceX just cut its share price from over $526 to roughly $105 with a 5-for-1 stock split - a move that signal...
NXT Wave Research | Sponsoredtc pixel
I had never heard of this 1888 account
An investment account dating back to 1888 has quietly delivered average annual returns of 29% over the last 25...
The Oxford Club | Sponsoredtc pixel
Everyone is obsessed with SpaceX. But that’s the wrong play…
A hedge fund legend who delivered a 279% return on cash in 2025 says Elon Musk is now executing the 'Final Pha...
Brownstone Research | Sponsoredtc pixel
BIGGER than the SpaceX IPO?
Jon Najarian believes the SpaceX IPO - potentially arriving as soon as June 9th - may not even be the biggest ...
Banyan Hill Publishing | Sponsoredtc pixel